Supplementary Figures 1-3 from Results of a Phase 1 Study of AME-133v (LY2469298), an Fc-Engineered Humanized Monoclonal Anti-CD20 Antibody, in FcγRIIIa-Genotyped Patients with Previously Treated Follicular Lymphoma

Authors :: Kristen N. Ganjoo
James E. Wooldridge
Brian K. Link
Mitchell R. Smith
Christopher A. Slapak
James G. Nelson
Barrett W. Allan
Susan P. Carpenter
Nam H. Dang
Damien M. Cronier
Maksim Pashkevich
Brad L. Pohlman
Sven de Vos
Andres Forero-Torres
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: PDF file - 122K

Tools